A genetic variant of Aurora kinase A promotes genomic instability leading to highly malignant skin tumors

Enrique C. Torchia, Yiyun Chen, Hong Sheng, Hiroshi Katayama, James Fitzpatrick, William R. Brinkley, Carlos Caulin, Subrata Sen, Dennis R. Roop

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Aurora kinase A (Aurora-A) belongs to a highly conserved family of mitotis-regulating serine/threonine kinases implicated in epithelial cancers. Initially we examined Aurora-A expression levels at different stages of human skin cancer. Nuclear Aurora-A was detected in benign lesions and became more diffused but broadly expressed in well and poorly differentiated squamous cell carcinomas (SCC), indicating that Aurora-A deregulation may contribute to SCC development. To mimic the overexpression of Aurora-A observed in human skin cancers, we established a gene-switch mouse model in which the human variant of Aurora-A (Phe31Ile) was expressed in the epidermis upon topical application of the inducer RU486 (Aurora-AGS). Overexpression of Aurora-A alone or in combination with the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA), did not result in SCC formation in Aurora-AGS mice. Moreover, Aurora-A overexpression in naive keratinocytes resulted in spindle defects in vitro and marked cell death in vivo, suggesting that the failure of Aurora-A to initiate tumorigenesis was due to induction of catastrophic cell death. However, Aurora-A overexpression combined with exposure to TPA and the mutagen 7,12-dimethylbenz(a)anthracene accelerated SCC development with greater metastastic activity than control mice, indicating that Aurora-A cannot initiate skin carcinogenesis but rather promotes the malignant conversion of skin papillomas. Further characterization of SCCs revealed centrosome amplification and genomic alterations by array CGH analysis, indicating that Aurora-A overexpression induces a high level of genomic instability that favors the development of aggressive and metastatic tumors. Our findings strongly implicate Aurora-A overexpression in the malignant progression of skin tumors and suggest that Aurora-A may be an important therapeutic target.

Original languageEnglish
Pages (from-to)7207-7215
Number of pages9
JournalCancer Research
Volume69
Issue number18
DOIs
Publication statusPublished - 2009
Externally publishedYes

Fingerprint

Aurora Kinase A
Genomic Instability
Skin
Neoplasms
Squamous Cell Carcinoma
Skin Neoplasms
Tetradecanoylphorbol Acetate
Carcinogenesis
Cell Death
Switch Genes
Centrosome
Protein-Serine-Threonine Kinases
Mutagens
Papilloma
Keratinocytes
Epidermis
Carcinogens

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A genetic variant of Aurora kinase A promotes genomic instability leading to highly malignant skin tumors. / Torchia, Enrique C.; Chen, Yiyun; Sheng, Hong; Katayama, Hiroshi; Fitzpatrick, James; Brinkley, William R.; Caulin, Carlos; Sen, Subrata; Roop, Dennis R.

In: Cancer Research, Vol. 69, No. 18, 2009, p. 7207-7215.

Research output: Contribution to journalArticle

Torchia, EC, Chen, Y, Sheng, H, Katayama, H, Fitzpatrick, J, Brinkley, WR, Caulin, C, Sen, S & Roop, DR 2009, 'A genetic variant of Aurora kinase A promotes genomic instability leading to highly malignant skin tumors', Cancer Research, vol. 69, no. 18, pp. 7207-7215. https://doi.org/10.1158/0008-5472.CAN-09-1059
Torchia, Enrique C. ; Chen, Yiyun ; Sheng, Hong ; Katayama, Hiroshi ; Fitzpatrick, James ; Brinkley, William R. ; Caulin, Carlos ; Sen, Subrata ; Roop, Dennis R. / A genetic variant of Aurora kinase A promotes genomic instability leading to highly malignant skin tumors. In: Cancer Research. 2009 ; Vol. 69, No. 18. pp. 7207-7215.
@article{6d29211eedd94c41957bdae698f7ef9b,
title = "A genetic variant of Aurora kinase A promotes genomic instability leading to highly malignant skin tumors",
abstract = "Aurora kinase A (Aurora-A) belongs to a highly conserved family of mitotis-regulating serine/threonine kinases implicated in epithelial cancers. Initially we examined Aurora-A expression levels at different stages of human skin cancer. Nuclear Aurora-A was detected in benign lesions and became more diffused but broadly expressed in well and poorly differentiated squamous cell carcinomas (SCC), indicating that Aurora-A deregulation may contribute to SCC development. To mimic the overexpression of Aurora-A observed in human skin cancers, we established a gene-switch mouse model in which the human variant of Aurora-A (Phe31Ile) was expressed in the epidermis upon topical application of the inducer RU486 (Aurora-AGS). Overexpression of Aurora-A alone or in combination with the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA), did not result in SCC formation in Aurora-AGS mice. Moreover, Aurora-A overexpression in naive keratinocytes resulted in spindle defects in vitro and marked cell death in vivo, suggesting that the failure of Aurora-A to initiate tumorigenesis was due to induction of catastrophic cell death. However, Aurora-A overexpression combined with exposure to TPA and the mutagen 7,12-dimethylbenz(a)anthracene accelerated SCC development with greater metastastic activity than control mice, indicating that Aurora-A cannot initiate skin carcinogenesis but rather promotes the malignant conversion of skin papillomas. Further characterization of SCCs revealed centrosome amplification and genomic alterations by array CGH analysis, indicating that Aurora-A overexpression induces a high level of genomic instability that favors the development of aggressive and metastatic tumors. Our findings strongly implicate Aurora-A overexpression in the malignant progression of skin tumors and suggest that Aurora-A may be an important therapeutic target.",
author = "Torchia, {Enrique C.} and Yiyun Chen and Hong Sheng and Hiroshi Katayama and James Fitzpatrick and Brinkley, {William R.} and Carlos Caulin and Subrata Sen and Roop, {Dennis R.}",
year = "2009",
doi = "10.1158/0008-5472.CAN-09-1059",
language = "English",
volume = "69",
pages = "7207--7215",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "18",

}

TY - JOUR

T1 - A genetic variant of Aurora kinase A promotes genomic instability leading to highly malignant skin tumors

AU - Torchia, Enrique C.

AU - Chen, Yiyun

AU - Sheng, Hong

AU - Katayama, Hiroshi

AU - Fitzpatrick, James

AU - Brinkley, William R.

AU - Caulin, Carlos

AU - Sen, Subrata

AU - Roop, Dennis R.

PY - 2009

Y1 - 2009

N2 - Aurora kinase A (Aurora-A) belongs to a highly conserved family of mitotis-regulating serine/threonine kinases implicated in epithelial cancers. Initially we examined Aurora-A expression levels at different stages of human skin cancer. Nuclear Aurora-A was detected in benign lesions and became more diffused but broadly expressed in well and poorly differentiated squamous cell carcinomas (SCC), indicating that Aurora-A deregulation may contribute to SCC development. To mimic the overexpression of Aurora-A observed in human skin cancers, we established a gene-switch mouse model in which the human variant of Aurora-A (Phe31Ile) was expressed in the epidermis upon topical application of the inducer RU486 (Aurora-AGS). Overexpression of Aurora-A alone or in combination with the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA), did not result in SCC formation in Aurora-AGS mice. Moreover, Aurora-A overexpression in naive keratinocytes resulted in spindle defects in vitro and marked cell death in vivo, suggesting that the failure of Aurora-A to initiate tumorigenesis was due to induction of catastrophic cell death. However, Aurora-A overexpression combined with exposure to TPA and the mutagen 7,12-dimethylbenz(a)anthracene accelerated SCC development with greater metastastic activity than control mice, indicating that Aurora-A cannot initiate skin carcinogenesis but rather promotes the malignant conversion of skin papillomas. Further characterization of SCCs revealed centrosome amplification and genomic alterations by array CGH analysis, indicating that Aurora-A overexpression induces a high level of genomic instability that favors the development of aggressive and metastatic tumors. Our findings strongly implicate Aurora-A overexpression in the malignant progression of skin tumors and suggest that Aurora-A may be an important therapeutic target.

AB - Aurora kinase A (Aurora-A) belongs to a highly conserved family of mitotis-regulating serine/threonine kinases implicated in epithelial cancers. Initially we examined Aurora-A expression levels at different stages of human skin cancer. Nuclear Aurora-A was detected in benign lesions and became more diffused but broadly expressed in well and poorly differentiated squamous cell carcinomas (SCC), indicating that Aurora-A deregulation may contribute to SCC development. To mimic the overexpression of Aurora-A observed in human skin cancers, we established a gene-switch mouse model in which the human variant of Aurora-A (Phe31Ile) was expressed in the epidermis upon topical application of the inducer RU486 (Aurora-AGS). Overexpression of Aurora-A alone or in combination with the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA), did not result in SCC formation in Aurora-AGS mice. Moreover, Aurora-A overexpression in naive keratinocytes resulted in spindle defects in vitro and marked cell death in vivo, suggesting that the failure of Aurora-A to initiate tumorigenesis was due to induction of catastrophic cell death. However, Aurora-A overexpression combined with exposure to TPA and the mutagen 7,12-dimethylbenz(a)anthracene accelerated SCC development with greater metastastic activity than control mice, indicating that Aurora-A cannot initiate skin carcinogenesis but rather promotes the malignant conversion of skin papillomas. Further characterization of SCCs revealed centrosome amplification and genomic alterations by array CGH analysis, indicating that Aurora-A overexpression induces a high level of genomic instability that favors the development of aggressive and metastatic tumors. Our findings strongly implicate Aurora-A overexpression in the malignant progression of skin tumors and suggest that Aurora-A may be an important therapeutic target.

UR - http://www.scopus.com/inward/record.url?scp=70349728482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349728482&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-09-1059

DO - 10.1158/0008-5472.CAN-09-1059

M3 - Article

C2 - 19738056

AN - SCOPUS:70349728482

VL - 69

SP - 7207

EP - 7215

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 18

ER -